NDA Panel2021ON-6384

Safety of a change in the conditions of use of galacto‐oligosaccharides as a novel food ingredient in food supplements pursuant to Regulation (EU) 2015/2283

ApplicantYakult Pharmaceutical Industry Co., Ltd.
SubstanceGalacto-oligosaccharides
QuestionEFSA-Q-2020-00211
DOI10.2903/j.efsa.2021.6384
DossierNF 2020/1607